- Tytuł:
-
Hypomethylating agents (HMAs) show benefit in AML rather than in intermediate/high-risk MDS based on genetic mutations in epigenetic modification (EMMs): from a retrospective study - Autorzy:
- Źródło:
- Annals of Hematology. 103(1):61-71
Czasopismo naukowe